Abstract

As important modulators in multiple physiological processes, microRNAs (miRNAs) have been reported in various malignant tumors, including breast cancer. The current study investigated the function of a new tumor suppressor microRNA, miR-488, and its molecular mechanism of metastasis in breast cancers. CCK8 and transwell assays revealed that the upregulated miR-488 level significantly inhibited the proliferation and migration of breast cancer cells. As a potential downstream gene, the mRNA and protein level of FSCN1 was suppressed by increased miR-488 and vice versa. Luciferase assay showed that miR-488 directly bind to the 3′UTR of FSCN1 and suppressed the translation process of FSCN1. The promoter region of miR-488 was directly bound by Notch3 and promoted the expression of miR-488 transcriptionally. Immunohistochemistry results revealed that in patients with breast cancer, the expression of Notch3 and were negatively correlated with the FSCN1 levels significantly. Therefore, the current finding predicted miR-488 as a tumor suppressor molecule in breast cancer, and demonstrated that Notch3/miR-488/FSCN1 axis is established and involved in regulating the metastasis of breast cancers, providing novel therapeutic targets for patients with breast cancers.

Details

Title
MicroRNA-488 inhibits proliferation and motility of tumor cells via downregulating FSCN1, modulated by Notch3 in breast carcinomas
Author
Wu, Yang 1   VIAFID ORCID Logo  ; Ming-Heng, Yuan 1   VIAFID ORCID Logo  ; Hua-Tao, Wu 2 ; Wen-Jia, Chen 3 ; Man-Li, Zhang 1 ; Qian-Qian, Ye 3 ; Liu, Jing 3   VIAFID ORCID Logo  ; Guo-Jun, Zhang 4 

 Shantou University Medical College, Changjiang Scholar’s Laboratory/Guangdong Provincial Key Laboratory for Diagnosis and Treatment of Breast Cancer, Shantou, China (GRID:grid.411679.c) (ISNI:0000 0004 0605 3373) 
 the First Affiliated Hospital of Shantou University Medical College, Department of General Surgery, Shantou, China (GRID:grid.412614.4) 
 Shantou University Medical College, Changjiang Scholar’s Laboratory/Guangdong Provincial Key Laboratory for Diagnosis and Treatment of Breast Cancer, Shantou, China (GRID:grid.411679.c) (ISNI:0000 0004 0605 3373); Shantou University Medical College, Department of Physiology/Cancer Research Center, Shantou, China (GRID:grid.411679.c) (ISNI:0000 0004 0605 3373) 
 Shantou University Medical College, Changjiang Scholar’s Laboratory/Guangdong Provincial Key Laboratory for Diagnosis and Treatment of Breast Cancer, Shantou, China (GRID:grid.411679.c) (ISNI:0000 0004 0605 3373); Xiang’an Hospital of Xiamen University, Department of Breast and Thyroid, 361101 Xiamen, China (GRID:grid.12955.3a) (ISNI:0000 0001 2264 7233) 
Publication year
2020
Publication date
Oct 2020
Publisher
Springer Nature B.V.
e-ISSN
20414889
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2471520669
Copyright
© The Author(s) 2020. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.